TNBC have a higher amount of tumor-infiltrating lymphocytes (TILs) [57] and higher PD-L1 protein [58, 59] or messenger RNA (mRNA) [60, 61] expression compared with other breast cancer subtypes. This evidence concerns the gene CD274 and breast cancer.